CRISPR-Cas technology: ETH researchers have uncovered a serious side effect
A molecule designed to make the process more efficient destroys parts of the genome
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
© 1997-2025 LUMITOS AG, All rights reserved